Bened Biomedical signed an exclusive distribution agreement with the European health company Beopanax to bring Psychobiotic PS128™ products to the new territories.
An agreement that empowers Beopanax, a health leading company at Ex-Yugoslavia territories, has been fully executed for exclusive distribution. In consonance with the accord, the sales territories will include Serbia, Kosovo, Bosnia, Montenegro, Macedonia, Croatia, Slovenia, and Albania.
The launch of the new exclusive product “Second Brain”, a sachet product containing 30B CFU of Lactobacillus plantarum PS128™, is slated for the first quarter of 2020.
The company, Beopanax doo Belgrade, has been in existence since 1997, evolved from herbal pharmacy, a STR Granary, is now fully engaged in the import and production of natural products and nutritional supplements which aim to improve the quality of life of modern man, through the unique business concept of "Health as style".
Both Bened and Beopanax are focused on finding new products that prove their worth through clinical studies and meet customer’s expectation.
The Managing Director of Beopanax, Tatjana Filippi, affirms: “It is common for all our partners to invest in R&D and have clinical studies for their products. From nature they choose unique substances that, through the process of high-tech production, are transformed into products of superior quality”.
“It’s inspiring that through close cooperation with a trustworthy partner such as Beopanax, we are able to successfully bring Psychobiotic PS128™ to the target market quickly and benefit more and more people around the world. Bened is already collaborating with many leading nutraceutical and pharmaceutical companies in Europe and the rest of the world. We are glad to announce our collaboration with the top Balkans health-oriented company Beopanax”, emphasized Frankie Cheng, CEO of Bened Biomedical.
Psychobiotic PS128™ keeps extending Europe outside the bound of the EU and is also targeting the CIS countries.